News | June 09, 2026
Wegovy pill smashes past 3mn prescriptions in under six months in US
The company said Wegovy hit its first one million prescriptions within 12 weeks of availability
The company said Wegovy hit its first one million prescriptions within 12 weeks of availability
Approved as a web-based pre-diagnostic tool for suspected rare diseases and classified as a Class A (non-sterile and non-measuring) medical device
Ariane brings a strong track record within Ardena, including her leadership of the company’s drug product division since 2022
SFDA nod marks company’s strategic entry into high-value specialty oncology injectables as it targets expanding stem cell transplant and haemato-oncology market in the GCC region
The approval has been secured in partnership with Yabao Pharmaceuticals, a major player in China’s paediatric medicine segment
We are building an AI-native operating system for pharma sales and distribution
Early implementation of West Synchrony S1 platform aims to accelerate biologics and vaccine development while reducing manufacturing risk for biopharma partners
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines
This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
